Mithra Pharmaceuticals S.A.

MITPF · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$174-$60-$117-$92
Dep. & Amort.$12$12$10$10
Deferred Tax$0-$57-$16-$38
Stock-Based Comp.$5$2$1$7
Change in WC$0-$31$6-$11
Other Non-Cash$155$67$29$41
Operating Cash Flow-$2-$67-$86-$84
Investing Activities
PP&E Inv.$0-$26-$21-$16
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$3-$0-$34-$6
Investing Cash Flow$3-$25-$55-$16
Financing Activities
Debt Repay.$0$45$26$122
Stock Issued$0$36$9$66
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$21-$4-$0$1
Financing Cash Flow-$21$88$35$189
Forex Effect-$0-$0$0$0
Net Chg. in Cash-$19-$5-$106$89
Supplemental Information
Beg. Cash$28$33$139$50
End Cash$9$28$33$139
Free Cash Flow-$2-$92-$107-$100
Mithra Pharmaceuticals S.A. (MITPF) Financial Statements & Key Stats | AlphaPilot